Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ATLAAC Trial
NCT06401616Phase 4Recruiting
- Sponsor
- University Hospital Odense
- Start
- May 2024
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Number of participants with ischemic strokes, peripheral arterial embolisms and major bleedings. Started May 2024; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06401616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06401616.